You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Enzalutamide

Showing 1 - 25 of 384
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Enzalutamide during Lead-in Period
  • +5 more
  • Myrtle Beach, South Carolina
    Research Site
Sep 9, 2022

Prostate Cancer Trial (ADT, Enzalutamide, Talazoparib)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
May 15, 2023

Prostatic Adenocarcinoma Trial in Seoul (Enzalutamide)

Not yet recruiting
  • Prostatic Adenocarcinoma
  • Enzalutamide
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Aug 23, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 12, 2023

Prostate Cancer Trial in Canada, United States (Enzalutamide, EPI-7386 with Enzalutamide)

Recruiting
  • Prostate Cancer
  • Enzalutamide
  • EPI-7386 with Enzalutamide
  • Port Saint Lucie, Florida
  • +8 more
Dec 13, 2022

Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)

Not yet recruiting
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Enzalutamide 40 MG
  • Docetaxel injection
  • (no location specified)
Jan 27, 2023

Prostate Cancer Trial run by the National Cancer Institute (NCI) (PROSTVAC-F/TRICOM, PROSTVAC-V/TRICOM, Enzalutamide (Xtandi))

Active, not recruiting
  • Prostate Cancer
  • PROSTVAC-F/TRICOM
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)

Terminated
Has Results
  • Metastatic Castration Resistant Prostate Cancer
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2022

Prostatic Tumors Trial in New York, Myrtle Beach, Houston (ORIC-101, enzalutamide 40 MG oral capsule [Xtandi])

Active, not recruiting
  • Prostatic Neoplasms
  • ORIC-101
  • enzalutamide 40 MG oral capsule [Xtandi]
  • New York, New York
  • +2 more
Sep 22, 2022

Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)

Active, not recruiting
  • Prostate Cancer
  • Enzalutamide
  • Metformin Hydrochloride
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 4, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Castration Resistant Metastatic Prostate Cancer Trial in Baltimore (Testosterone cypionate, Enzalutamide, Testosterone

Recruiting
  • Castration Resistant Metastatic Prostate Cancer
  • Testosterone cypionate
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Aug 4, 2022

Metastatic Prostate Cancer Trial in Toronto (Enzalutamide, Standard of Care SBRT and ADT)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Enzalutamide
  • Standard of Care SBRT and ADT
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Center
Oct 6, 2022

Medicines Called Enzalutamide and Abiraterone in People With

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Enzalutamide
  • Abiraterone acetate
  • New York, New York
    Pfizer Inc
Jul 21, 2023

Prostate Cancer, Castration-resistant Prostate Cancer Trial in São Paulo (Docetaxel, Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Castration-resistant Prostate Cancer
  • São Paulo, SP, Brazil
    Instituto do Câncer do Estado de São Paulo
Sep 14, 2022

Darolutamide, Enzalutamide and Apalutamide and How Well These

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Whippany, New Jersey
    Bayer
Aug 25, 2023

Called DEAR, to Learn More About Treatment With Darolutamide,

Active, not recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Whippany, New Jersey
    Bayer
Jan 13, 2023

Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)

Not yet recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023

COVID-19 Infection Trial in Bellinzona (Enzalutamide)

Terminated
  • COVID-19 Infection
  • Enzalutamide
  • Bellinzona, Switzerland
    Oncology Institute of Southern Switzerland (IOSI)
Aug 7, 2022

Cancer of the Prostate, Prostate Cancer Trial in Switzerland (Enzalutamide, Metformin)

Active, not recruiting
  • Cancer of the Prostate
  • Prostate Cancer
  • Aarau, Switzerland
  • +15 more
Jun 9, 2022

Metastatic Castration Resistant Prostate Cancer Trial in India (Enzalutamide, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Enzalutamide
  • Androgen deprivation therapy (ADT)
  • Ahmedabad, India
  • +7 more
Jan 21, 2023

Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)

Not yet recruiting
  • Metastatic Cancer
  • Neoplasm, Prostate
  • Abiraterone acetate
  • +2 more
  • Bronx, New York
    James J. Peters VA Medical Center
Jun 16, 2022

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United

Recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Feb 2, 2023

Prostate Cancer Trial in Utrecht (PSMA-PET/CT response evaluation)

Not yet recruiting
  • Prostate Cancer
  • PSMA-PET/CT response evaluation
  • Utrecht, Netherlands
    Roderick van den Bergh
Sep 10, 2022

Prostatic Tumors, Castration-Resistant Trial in New York (TVB-2640, Enzalutamide)

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Feb 23, 2023